Incidence of Chronic Inflammatory Rheumatic Diseases in Finland during 1975–1990

Kaipiainen‐Seppänen, Oili

doi:10.3109/03009749709065692

Cited by 34 publications

(41 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A similar approach was used in a study from Finland, where the incidence was 46 in females and 25 in males [8]. On the basis of data from a drug reimbursement register in Finland, the incidence of RA was 43 in females and 24 in males in 1995 [9]. In our study, the rates were close to the ones reported from Finland where data were collected from several sources including primary health care.…”

Section: Discussionsupporting

confidence: 61%

“…Using different sets of classification criteria, incidence rates per 100 000 person-years (PY) have in most studies without restrictions as to the age of the study population ranged from 26 to 58 in females, from 12 to 30 in males, and from 21 to 45 in females and males combined [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]. RA is seen more often in females with an overall female to male ratio of two to three.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001

Pedersen¹,

Svendsen²,

Hørslev‐Petersen³

2007

TORJ

View full text Add to dashboard Cite

Abstract:We estimated the incidence of rheumatoid arthritis in the southern part of Denmark from 1995 to 2001. At a rheumatology hospital serving a population of about 200 000 people over the age of 15, medical records were scrutinized. As case definition we used the tree and list format of 1987 American College of Rheumatology criteria for rheumatoid arthritis. The mean annual incidence rate per 100 000 person years was 40 in females, 21 in males, and 31 in females and males combined. The incidence of rheumatoid arthritis in Denmark is in accordance with recent studies from North America, the UK, and Northern European countries. The aetiology of rheumatoid arthritis is unknown but this study indicates that in these populations the exposure to non-genetic host and environmental aetiological factors is similar.

show abstract

Section: Discussionsupporting

confidence: 61%

Section: Introductionmentioning

confidence: 99%

Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001

Pedersen¹,

Svendsen²,

Hørslev‐Petersen³

2007

TORJ

View full text Add to dashboard Cite

show abstract

“…However, patients with AS who do not require or no longer require disease-specific pharmacologic treatment are not registered in this material, which could reflect a potential underestimate of AS incidence. However, the same group has conducted another survey on the incidence of rheumatic diseases, where the diagnosis of AS was confirmed by radiology, and found a similar figure for AS incidence (6.3 per 100,000 personyears) (17). Therefore, in spite of these differences in approach, the incidence of primary AS in Northern Norway based on hospitalized patients is comparable with the incidence of primary and secondary AS in Rochester, Minnesota and with the reported incidence of AS in Finland.…”

Section: Discussionmentioning

confidence: 96%

Incidence and prevalence of ankylosing spondylitis in Northern Norway

Bakland¹,

Nossent²,

Gran³

2005

Arthritis & Rheumatism

129

View full text Add to dashboard Cite

Objective. To determine the incidence and prevalence of ankylosing spondylitis (AS) over a prolonged period in the 2 northernmost counties of Norway, where HLA-B27 has a high prevalence in the population. Methods. We conducted a cohort study of all patients registered with a diagnosis of AS between 1960 and 1993 at the University Hospital of Northern Norway, which is the sole rheumatology department serving these counties. We registered demographics, year of disease onset (clinical disease), and year of diagnosis (radiograph confirmation) for all patients. The date of onset of clinical disease in patients with AS was used in the calculation of incidence rates. Annual incidence and point/period prevalence rates were expressed per 100,000 adults. Primary AS was defined as AS in the absence of psoriasis or inflammatory bowel disease (IBD).

show abstract

“…детей и распространен-ности в диапазоне от 1,89 до 25,7 на 100 тыс. детей во всем мире, включая Европу [10][11][12][13][14][15][16][17], СКВ с ювенильным дебю-том попадает в Европе в категорию орфанных заболева-ний [18]. Ее низкая распространенность усложняет про-ведение полномасштабных клинических исследований и создание международных рекомендаций по лечению и мониторингу подобных пациентов.…”

unclassified

Psychiatric Illness of Systemic Lupus Erythematosus in Childhood: Spectrum of Clinically Important Manifestations

Lim

Lefebvre²,

Benseler³

et al. 2012

J Rheumatol

View full text Add to dashboard Cite

Современные международные рекомендации по диагностике и лечению системной красной волчанки с ювенильным дебютом Каледа М.И., Никишина И.П.Системная красная волчанка (СКВ) с дебютом в детском и подростковом возрасте представляет существен-ную проблему в практике педиатров и ревматологов ввиду диагностических сложностей, особенностей тече-ния и большей вероятности неблагоприятного прогноза. До 20% больных СКВ заболевают в возрасте млад-ше 18 лет. Только у 13% пациентов с ювенильным дебютом во взрослом состоянии имеется безмедикамен-тозная ремиссия при более низком, чем в популяционном контроле, качестве жизни. Статья посвящена об-суждению последних международных рекомендаций по диагностике, мониторингу и лечению СКВ у детей и подростков, опубликованных в 2017 г., с комментариями, основанными на данных литературы и на прак-тическом опыте ведения подобных пациентов. Ключевые слова: системная красная волчанка; клинические рекомендации; детский возраст. Для ссылки: Каледа МИ, Никишина ИП. Современные международные рекомендации по диагностике и ле-чению системной красной волчанки с ювенильным дебютом. Научно-практическая ревматология. 2018;56(4):405-415. CURRENT INTERNATIONAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUSKaleda M.I., Nikishina I.P.Systemic lupus erythematosus (SLE) with its onset in childhood or adolescence is a significant problem in the practice of pediatricians and rheumatologists due to diagnostic difficulties, clinical features, and the greater likelihood of unfavorable prognosis. About 20% of SLE patients fall ill at the age of 18 years. Only 13% of patients with juvenile-onset SLE have a drug-free remission in adulthood and have a lower quality of life than population controls. The paper discusses the latest international guidelines for the diagnosis, monitoring, and treatment of SLE in children and adolescents, which were published in 2017, with comments based on the data available in the literature and on practical experiences in managing these patients.

show abstract

Incidence of Chronic Inflammatory Rheumatic Diseases in Finland during 1975–1990

Cited by 34 publications

References 0 publications

Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001

Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001

Incidence and prevalence of ankylosing spondylitis in Northern Norway

Psychiatric Illness of Systemic Lupus Erythematosus in Childhood: Spectrum of Clinically Important Manifestations

Contact Info

Product

Resources

About